| Literature DB >> 33915977 |
Luca Finetti1, Thomas Roeder2,3, Girolamo Calò4, Giovanni Bernacchia1.
Abstract
Tyramine is a neuroactive compound that acts as neurotransmitter, neuromodulator, and neurohormone in insects. Three G protein-coupled receptors, TAR1-3, are responsible for mediating the intracellular pathway in the complex tyraminergic network. TAR1, the prominent player in this system, was initially classified as an octopamine receptor which can also be activated by tyramine, while it later appeared to be a true tyramine receptor. Even though TAR1 is currently considered as a well-defined tyramine receptor and several insect TAR1s have been characterized, a defined nomenclature is still inconsistent. In the last years, our knowledge on the structural, biochemical, and functional properties of TAR1 has substantially increased. This review summarizes the available information on TAR1 from different insect species in terms of basic structure, its regulation and signal transduction mechanisms, and its distribution and functions in the brain and the periphery. A special focus is given to the TAR1-mediated intracellular signaling pathways as well as to their physiological role in regulating behavioral traits. Therefore, this work aims to correlate, for the first time, the physiological relevance of TAR1 functions with the tyraminergic system in insects. In addition, pharmacological studies have shed light on compounds with insecticidal properties having TAR1 as a target and on the emerging trend in the development of novel strategies for pest control.Entities:
Keywords: G protein-coupled receptor; monoterpenes; octopamine; pharmacology; physiology; tyramine
Year: 2021 PMID: 33915977 PMCID: PMC8065976 DOI: 10.3390/insects12040315
Source DB: PubMed Journal: Insects ISSN: 2075-4450 Impact factor: 2.769
Molecular features of TAR1s cloned from insects.
| Species | Accession number | Amino Acid Sequence Lenght | Residues Interacting with TA | N-Linked Glycosylation | P Sites | IL3 Lenght | Reference |
|---|---|---|---|---|---|---|---|
|
| AAA28731 | 601 | / | N11; N57 | T136; T296; S375; S397; S406; S482; S507 | 237 | [ |
|
| MK405664 | 600 | D187; S271; S272; S275 | N11; N55 | S420; S506; S519 | 238 | [ |
|
| AB621975 | 607 | / | / | / | 246 | [ |
|
| X69520 | 484 | D130 | N13; N198 | T78; T164; T238; T300; S304; S365; S372 | 174 | [ |
|
| AJ245824 | 399 | D116; S200: S201; S204 | N2 | T63; T149; T223; S241; T265; S291; S292; T296 | 110 | [ |
|
| X95607 | 479 | D134; S218; S222 | N11; N16 | T81; T241; T258; T302 | 162 | [ |
|
| CAA64864 | 477 | D132 | N11; N16 | T78; T238; T298; T302 | 165 | [ |
|
| AM990461 | 441 | D115; S199; W381; N418 | N12,N17 | T61; T222; S275; S285; S326; T334; S341 | 144 | [ |
|
| LT900530 | 481 | D120; S204; S208 | N7; N17 | S64; T153; T227; S238; S252; T279; T280; S282; T289; S300; T350; T351; S354; S379; S398; P408 | 188 | [ |
|
| AFG26689.1 | 478 | D135; S219; S223 | N11; N16; N347 | T205; T267; S274; T304; S315; T371; S396 | 170 | [ |
|
| MF377527 | 447 | / | N14; N17 | T75; T235; S246; S265; S271; S274; S295; S298; S311; S319; S320; S322; S338; T354; S371; S373 | 161 | [ |
|
| MK166023 | 467 | D127; S211; S215 | N5; N10 | S252; S268; S271; T296; S307; S322; S349; S352; S385 | 168 | [ |
|
| MT513133 | 449 | D128; S212; S213; S216 | N11; N14; N22 | S24; T30; T161; T235; S246; S260; S294; S319; S321; S364 | 147 | [ |
|
| AF343878 | 477 | D136 | / | / | 174 | [ |
|
| AB182633 | 475 | D131 | / | / | 171 | [ |
|
| FJ640850 | 477 | D149; S216; S217; S220 | N11; N16; N345 | T79; T165; T239; T265; S314; S333; S383 | 177 | [ |
|
| A0A0S1VX60 | 455 | V83; D114; C118; W394; N427; S428 | / | / | 158 | [ |
Functional and pharmacological properties of TAR1s cloned from insects.
| Species | G-Protein | pEC50 TA | pEC50 OA | Cell Line Used | Antagonist | Reference |
|---|---|---|---|---|---|---|
|
| Gi | 5.62 | 4.52 | Cos-7 | Yohimbine (tested at 1 µM) | [ |
| Gi | 5.24 | / | S2 | / | [ | |
|
| Gq | 6.35 | Detectable to 10 µM | HEK 293 | Yohimbine: pA2 7.87 | [ |
| Gq+Gi | 6.86 | Yohimbine: pA2 7.24 | ||||
|
| Gq | 7.33 | Detectable to 10 µM | Murine Erythroleukaemia | Yohimbine (tested at 2.5 µM) | [ |
| Gi | 8.40 | / | / | |||
|
| Gi | 6.86 | 5.56 | HEK 293 | / | [ |
| Gi | 7.07 | / | Sf9 | / | [ | |
|
| Gi | 8.28 | 5.85 | HEK 293 | Yohimbine > Chlorpromazine > Metoclopramide > Mianserin (tested at 10 µM) | [ |
|
| Gi | 6.46 | / | HEK 293 | Yohimbine and Chlorpromazine > Mianserin (tested at 10 µM) | [ |
|
| Gi | 8.20 | / | HEK 293- CNG | Yohimbine: pA2 6.13 | [ |
|
| Gi | 6.43 | 6.01 | HEK 293 | Yohimbine > Chlorpromazine > Cyproheptadine (tested at 10 µM) | [ |
|
| Gq | 7.29 | 5.16 | HEK 293- CNG | Yohimbine > Metoclopramide > Phentolamine > Cyproheptamide > Gramine > Mianserin > Chlorpromazine (tested at 10 µM) | [ |
|
| Gi | 6.35 | 4.86 | HEK 293T | Yohimbine > Mianserin > Phentolamine > Chlorpromazine (tested at 10 µM) | [ |
|
| Gq | 5.99 | 4.41 | HEK 293 | Yohimbine: pA2 8.26 | [ |
Figure 1Intracellular signaling pathways trigged by TAR1 activation. ATP (Adenosine triphosphate), cAMP (Cyclic adenosine monophosphate), PLCβ (phospholipase Cβ), PIP2 (Phosphatidylinositol 4,5-bisphosphate), IP3 (Inositol trisphosphate), DAG (Diacylglycerol), ER (Endoplasmatic reticulum).
Figure 2Revised scheme, based on Hana and Lange, describing the tyramine (TA)/octopamine (OA) receptors classification based on their sensitivity to ligands and their downstream effects [45].